Bausch Health Companies Inc. (NYSE:BHC) has appointed Steven Lee as its new Senior Vice President, Controller, and Chief Accounting Officer, effective July 14. Lee brings over two decades of experience in financial transformation, mergers and acquisitions, and operational execution. Prior to joining Bausch Health, he served as Vice President and Chief Financial Officer at Brandsafway, as well as Vice President and Chief Accounting Officer at the same company. He also held various senior financial and operational management positions at Mohawk Industries.
In his new role, Lee will oversee the company’s financial reporting and corporate controllership. This appointment comes as Bausch Health continues its transformation journey towards innovation and profitable growth.
Bausch Health Companies Inc. is a global, diversified pharmaceutical company focused on developing, manufacturing, and marketing products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals, and eye health, through its controlling interest in Bausch + Lomb Corporation. The company aims to be a globally integrated healthcare company, trusted and valued by patients, healthcare professionals, employees, and investors. Today the company's shares have moved 0.46% to a price of $6.62. For the full picture, make sure to review Bausch Health's 8-K report.
